Family study for inherited lung scarring causes
Part of Lungs & breathing clinical trials.
This study looks at what causes familial (inherited) pulmonary fibrosis by studying relatives who are not yet diagnosed with the lung disease. You may help researchers understand risk and early changes in the lungs within families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a sibling or adult child of someone in your family with the lung condition
- At least two relatives in the family should be known to have idiopathic interstitial pneumonia (IIP)
- You personally must NOT have a diagnosis of IIP or IPF (pulmonary fibrosis)
- You must be able to travel to Nashville for 1–2 outpatient visits and complete a lung questionnaire
- Your age must be between 40 and 75 (with a limited extra allowance if your relative was diagnosed before age 50)
- You must not have other illnesses or exposures that could explain similar symptoms (like certain autoimmune diseases or work-related lung disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for genetic causes of pulmonary fibrosis that runs in families. You and your affected family member(s) would provide blood samples and health info to help researchers understand why lung scarring happens.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study looks at people with a condition called idiopathic pulmonary fibrosis (IPF), which causes lung scarring. Researchers want to develop a tool to predict how the disease will progress, so they will collect health data over time to see what factors affect outcomes.
This study looks at genetic (DNA) and protein changes over time in people with idiopathic pulmonary fibrosis, to better understand how the disease progresses. Your participation may help researchers learn patterns that could guide future care.
Hear when a new Familial Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.